EDRIE WICHERN: Open Payments
NPI 1598933533 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,640 in 128 payments from 15 companies in 2025. Trend: 2023 $1,918 · 2024 $2,162 · 2025 $2,640
Food & beverage: $2,563Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $554 |
| Janssen Biotech, Inc. | 12 | $284 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $279 |
| Ardelyx, Inc. | 4 | $201 |
| Ipsen Biopharmaceuticals, Inc | 7 | $200 |
| Gilead Sciences, Inc. | 9 | $190 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $184 |
| Madrigal Pharmaceuticals | 12 | $181 |
| Regeneron Healthcare Solutions, Inc. | 5 | $127 |
| GENZYME CORPORATION | 4 | $113 |
Products named: RINVOQ, TREMFYA, DUPIXENT, IBSRELA, IQIRVO, LINZESS, REZDIFFRA, XIFAXAN.
Industry payments across MO — which companies pay providers there.
